BIO heralds rules on genetically designed animals

The FDA has issued new rules governing the sale of products developed from genetically engineered animals--a field that includes the use of animals to produce lower cost therapeutics. The agency says that before any such product is approved for sale it will be subjected to an independent committee review. An exception is being made for research animals. "This system will ensure the products made available through this science will go through a rigorous and transparent review process before being approved for the marketplace," said Barbara Glenn, a senior scientific adviser with the Biotechnology Industry Organization. Report

Suggested Articles

The data, from two patients with severe blood disorders, are "promising” for what could be a one-and-done treatment, Cantor Fitzgerald analysts wrote.

The fund will back pharma companies as well as developers of medtech products and providers of outsourced services.

The money will fund work to develop polymers in multiple indications and an associated U.S. expansion.